Understanding NF2: Diagnosis, Management and Challenges
CereXis and NF2 BioSolutions invite you to learn about NF2 from the experts. Our panelists include Dr. D. Bradley Welling, Chief of Otolaryngology–Head and Neck Surgery at Massachusetts Eye and Ear and Prof D Gareth Evans, Professor of Med. Genetics and Cancer Epidemiology, The University of Manchester, UK.
We will hear from Dr. John Mekalanos from Harvard Medical School and Dr. Gary Brenner from Massachusetts General Hospital about how their labs are working with genetically modified bacteria to kill NF2 tumor cells and how you can support this exciting new project!
New hope for NF2 – Gene Therapy 101 – May 22nd, 2020
For our first ever NF2 gene therapy webinar! Chief Scientific Officer Dr. Edgar Rodríguez-Lebrón is presenting Gene Therapy 101 to give us a better understanding of how gene therapy works and what types of therapies are most promising for curing NF2. You will not want to miss this!